Multiple Sclerosis Journal · 2021 · 54 citations · 25 references
MedicineNeurologyOphthalmologyNeuro-ophthalmologyNeuropathologyOcular DiseaseMultiple SclerosisOptic NeuritisOptic NeuropathiesRetinal DiseaseRetinal DisordersRetinal PathologyFoveal Avascular Zone MorphometryFoveal ThicknessNeuroinflammatory BiomarkersNeuroinflammatory MarkersOptical Coherence Tomography AngiographyOptical Coherence Tomography BiomarkersOptical Coherence Tomography FindingsRetinal Vasculature Imaging
Background: Neuromyelitis optica spectrum disorders (NMOSD) are neuroinflammatory diseases of the central nervous system. Patients suffer from recurring relapses and it is unclear whether relapse-independent disease activity occurs and whether this is of clinical relevance. Objective: To detect disease-specific alterations of the retinal vasculature that reflect disease activity during NMOSD. Methods: Cross-sectional analysis of 16 patients with NMOSD, 21 patients with relapsing-remitting multiple sclerosis, and 21 healthy controls using retinal optical coherence tomography (OCT), optical coherence tomography angiography (OCT-A), measurement of glial fibrillary acidic protein (GFAP) serum levels, and assessment of visual acuity. Results: Patients with NMOSD but not multiple sclerosis revealed lower foveal thickness (FT) ( p = 0.02) measures and an increase of the foveal avascular zone (FAZ) ( p = 0.02) compared to healthy controls independent to optic neuritis. Reduced FT ( p = 0.01), enlarged FAZ areas ( p = 0.0001), and vessel loss of the superficial vascular complex ( p = 0.01) were linked to higher serum GFAP levels and superficial vessel loss was associated with worse visual performance in patients with NMOSD irrespective of optic neuritis. Conclusion: Subclinical parafoveal retinal vessel loss might occur during NMOSD and might be linked to astrocyte damage and poor visual performance. OCT-A may be a tool to study subclinical disease activity during NMOSD.
25
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Dean M. Wingerchuk, Brenda Banwell, Jeffrey L. Bennett et al. · Neurology · 2015 · 4.5K citations · Full text
Medicine, Neurology, Neuroscience +15
Annabel M. Ruiter, Rosemarijn R. J. Somanje-Bolweg, Erik van Gorsel et al. · PubMed · 2017 · 1.8K citations · Full text
Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis
Giulio Disanto, Christian Barro, Pascal Benkert et al. · Annals of Neurology · 2017 · 1.2K citations · Full text
Blood neurofilament light chain as a biomarker of MS disease activity and treatment response
Jens Kühle, Harald Kropshofer, Dieter Haering et al. · Neurology · 2019 · 564 citations · Full text
Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria
Sven Schippling, LJ Balk, Fiona Costello et al. · Multiple Sclerosis Journal · 2014 · 305 citations · Full text
Medicine, Neurology, Ophthalmology +16